Inventor · disambiguated record
Xuri Li
Also filed as: LI XURI
5 granted patents·14 pending applications·27 citations·filing 1998–2018
77Inventor score
Files withLUDWIG INST CANCER RES10LI XURI2LICENTIA LTD2ZHONGSHAN OPHTHALMIC CT SUN YAT SEN UNIV2LUDWIG INST FOR CANCER RES LTD1
Top patents by PatentIndex Score
19 records- 0173US7148037B2Platelet-derived growth factor D, DNA coding therefor, and uses thereofLICENTIA LTD·Filed 2002·Granted Dec 12, 2006·4 cites·12 claims
- 0272US7709450B2Stimulation of vascularization with VEGF-B-186LUDWIG INST CANCER RES·Filed 2002·Granted May 4, 2010·6 cites·11 claims
- 0358US2004053837A1Composition and method for modulating vasculogenesis or angiogenesisLUDWIG INST CANCER RES·Filed 2003·Application pending·0 cites
- 0458US2007042413A1Platelet-derived growth factor D, DNA coding therefor, and uses thereofLICENTIA LTD·Filed 2006·Application pending·0 cites
- 0558US2006104978A1Methods and compositions for PDGF-C activation and inhibitionLUDWIG INST CANCER RES·Filed 2004·Application pending·0 cites
- 0656US7034200B2Non-human transgenic animals expressing platelet-derived growth factor C (PDGF-C) and uses thereofLUDWIG INST CANCER RES·Filed 2001·Granted Apr 25, 2006·3 cites·17 claims
- 0754US6670125B2Methods for detecting for the presence of tumor cells and for screening for anti-tumor agentsLUDWIG INST CANCER RES·Filed 2001·Granted Dec 30, 2003·1 cites·21 claims
- 0854US2007172423A1Composition and method for modulating vasculogenesis for angiogenesisLI XURI·Filed 2006·Application pending·0 cites
- 0951US2009047284A1Methods and compositions for PDGF-C activation and inhibitionLUDWIG INST CANCER RES·Filed 2007·Application pending·0 cites
- 1050US2003211994A1Composition and method for modulating vasculogenesis or angiogenesisLUDWIG INST CANCER RES·Filed 2002·Application pending·0 cites
- 1149US2010221254A1Methods and Compositions for PDGF-C Activation and InhibitionLUDWIG INST FOR CANCER RES LTD·Filed 2010·Application pending·0 cites
- 1248US2005250103A1Methods for detecting for the presence of tumor cells and for screening for anti-tumor agentsLUDWIG INST CANCER RES·Filed 2003·Application pending·0 cites
- 1345US2004248796A1VEGF-B and PDGF modulation of stem cellsFiled 2004·Application pending·0 cites
- 1445US2019060404A1Use of vegf-b for treating diseases involving neoangiogenesisZHONGSHAN OPHTHALMIC CT SUN YAT SEN UNIV·Filed 2018·Application pending·0 cites
- 1544US6262337B1Transgenic animal with recombinant vascular endothelial growth factor B (VEGF-B DNA) and uses thereofLUDWIG INST CANCER RES·Filed 1998·Granted Jul 17, 2001·13 cites·14 claims
- 1644US2019062391A1Use of vegf-b for treating diseases induced by oxidative injuryZHONGSHAN OPHTHALMIC CT SUN YAT SEN UNIV·Filed 2018·Application pending·0 cites
- 1744US2011318365A1Methods for treatment of degenerative disease associated with apoptosisLI XURI·Filed 2008·Application pending·0 cites
- 1840US2002164687A1Platelet-derived growth factor C, DNA coding therefor, and uses thereofFiled 2001·Application pending·0 cites
- 1940US2005214280A1Method for inhibiting tumor formation and growthLUDWIG INST CANCER RES·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Xuri Li files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →